4.8 Review

The role of dendritic cells and their immunometabolism in rheumatoid arthritis

Journal

FRONTIERS IN IMMUNOLOGY
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1161148

Keywords

rheumatoid arthritis; immunometabolism; dendritic cell (DC); glycolysis (glycolytic pathway); OXPHOS (oxidative phosphorylation)

Categories

Ask authors/readers for more resources

Dendritic cells (DCs) have important roles in the pathogenesis of rheumatoid arthritis (RA), characterized by chronic synovitis and joint destruction. Conventional dendritic cells (cDCs) in the synovium show enhanced migratory capacities and T cell activation compared to peripheral blood cDCs, while plasmacytoid dendritic cells in RA may have tolerogenic effects. Monocyte-derived dendritic cells (moDCs) in the synovium induce expansion of T-helper 17 cells and proinflammatory cytokine production. Recent studies suggest a link between proinflammatory hypoxic environments in the synovium and metabolic reprogramming of DCs. Targeting the immunometabolism of DCs could be a potential therapeutic approach in RA.
Dendritic cells (DCs) play crucial roles in the pathogenesis of rheumatoid arthritis (RA), a prototypic autoimmune disease characterized by chronic synovitis and joint destruction. Conventional dendritic cells (cDCs) with professional antigen-presenting functions are enriched in the RA synovium. In the synovium, the cDCs are activated and show both enhanced migratory capacities and T cell activation in comparison with peripheral blood cDCs. Plasmacytoid dendritic cells, another subtype of DCs capable of type I interferon production, are likely to be tolerogenic in RA. Monocyte-derived dendritic cells (moDCs), once called inflammatory DCs, are localized in the RA synovium, and they induce T-helper 17 cell expansion and enhanced proinflammatory cytokine production. Recent studies revealed that synovial proinflammatory hypoxic environments are linked to metabolic reprogramming. Activation of cDCs in the RA synovium is accompanied by enhanced glycolysis and anabolism. In sharp contrast, promoting catabolism can induce tolerogenic DCs from monocytes. Herein, we review recent studies that address the roles of DCs and their immunometabolic features in RA. Immunometabolism of DCs could be a potential therapeutic target in RA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available